Litigation Details for Noven Pharmaceuticals Inc. v. Actavis Laboratories UT Inc. (D. Del. 2015)
✉ Email this page to a colleague
Noven Pharmaceuticals Inc. v. Actavis Laboratories UT Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-03-20 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 8,231,906 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Noven Pharmaceuticals Inc. v. Actavis Laboratories UT Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Noven Pharmaceuticals Inc. v. Actavis Laboratories UT Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-03-20 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,231,906 B2;. (els) (Entered… 20 March 2015 1:15-cv-00249-LPS Patent None District Court, D. Delaware | External link to document | |
| 2016-07-05 | 98 | alleging infringement of U.S. Patent No. 8,231,906 (the '"906 patent"), which is directed to…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification …ultimate question of the proper construction of a patent is a question oflaw. See Teva Pharm. USA, Inc.…light of the statutes and policies that inform patent law." Id. "[T]he words of a claim | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
